Pharmacy Asset vs Stock Purchase: Which Is Better?
The pharmacy asset vs stock purchase decision is one of the first structural questions in any acquisition. It determines what the buyer actually acquires, which liabilities come along, how licenses and PBM contracts are handled, how taxes fall on each side and how a lender will document the loan.
Neither structure is better in every case. The right answer depends on the pharmacy’s contracts, its history, the parties’ tax positions and what lenders and state rules allow. This guide explains the trade-offs at a high level. Rules vary by state and payer, and nothing here is legal, tax, billing or compliance advice. Buyers and sellers should rely on healthcare counsel and accountants for their specific deal.
What Is an Asset Purchase?
In an asset purchase, the buyer’s entity acquires selected assets of the seller’s business, such as inventory, equipment, prescription files, goodwill and the right to use the trade name. The seller’s legal entity remains with the seller, along with most of its historical liabilities unless the buyer specifically agrees to assume them.
Because the buying entity is new to the pharmacy, licenses, registrations, enrollments and network contracts generally must be obtained, assigned or re-established for that entity.
What Is a Stock Purchase?
In a stock purchase (or a purchase of membership interests in an LLC), the buyer acquires the ownership of the existing legal entity. The entity itself continues, with its contracts, permits, history and liabilities. Only the owners change.
Even so, many state boards, payers and PBMs treat a change in control as a reportable event, and some require approval or new applications. Contracts and licenses should not be assumed to continue unchanged simply because the entity stays the same.
Pharmacy Asset vs Stock Purchase: Key Differences
- Liabilities: an asset purchase generally lets the buyer leave many pre-closing liabilities with the seller; a stock purchase transfers the entity with its history, including potential audit recoupments, tax issues or claims
- Licenses and registrations: an asset purchase usually requires new or transferred permits for the buyer’s entity; a stock purchase may allow some to continue with notice or approval, depending on state rules
- PBM and payer contracts: in an asset deal, contracts may need assignment with consent or new applications; in a stock deal, contracts may continue, though change-of-control provisions can still apply
- Taxes: buyers often prefer asset deals for potential tax benefits from allocating price to assets; sellers may prefer stock deals for different tax reasons, and accountants should model both
- Complexity: asset deals require transferring individual assets and contracts; stock deals may be simpler mechanically but require deeper diligence
Why PBM Contracts Often Drive the Decision
For an independent pharmacy, network participation is often the lifeblood of the business. If an asset purchase would require the buyer to apply for new PBM contracts and there is a risk of a gap, a stock purchase may look appealing. On the other hand, a stock purchase means the buyer inherits the entity’s audit history and any open recoupments.
Buyers should map each major contract, ask how it treats assignment and change of control, and discuss timing with counsel. Our article on pharmacy change of ownership walks through the licenses and contracts that typically need attention.
How Lenders View Each Structure
Lenders want the loan secured by the business that generates the cash flow and want assurance the pharmacy can keep billing after closing. Depending on the lender and program, they may:
- Take a lien on the assets acquired in an asset purchase
- Take a pledge of the acquired ownership interests and a lien on the entity’s assets in a stock purchase
- Require stronger diligence, indemnities or escrows when a stock purchase brings historical liabilities
- Condition funding on evidence that key licenses and contracts are in place or in process
SBA-backed loans can be used for either structure in some cases, subject to eligibility, use of proceeds, program rules and lender review. Our overview of SBA loans for pharmacy acquisition explains how they generally work. Every loan is subject to approval, and nothing here is a commitment to lend.
Diligence Matters More in a Stock Deal
Because the entity’s past comes with it, a stock purchase calls for especially thorough review of tax filings, PBM and payer audits, DIR fee reconciliations, employment matters, litigation and regulatory history. Purchase agreements often include representations, warranties and indemnification provisions to address unknown liabilities. Our pharmacy due diligence checklist is a helpful starting point.
Taxes and Price Allocation
In an asset purchase, the parties allocate the price among inventory, equipment, goodwill, non-compete agreements and other assets. That allocation can affect each side’s taxes significantly. Our article on taxes when selling a pharmacy introduces the basics, and accountants should advise on the specific allocation.
Inventory is often handled separately from the base price in either structure. See our article on pharmacy inventory valuation at closing for how counts may affect the final number.
Questions to Discuss With Advisors
- Which contracts and licenses can be assigned, and which require new applications?
- What known or potential liabilities does the entity carry?
- How would each structure affect taxes for both buyer and seller?
- What will our lender require for each structure?
- Can indemnities, escrows or holdbacks address remaining risks?
Final Thoughts
The pharmacy asset vs stock purchase choice shapes almost every part of a deal, from PBM contract continuity to liability exposure, taxes and loan documentation. An asset deal may offer cleaner liability separation, while a stock deal may offer more contract continuity with more inherited risk. Working with healthcare counsel, accountants and a lender early can help buyers choose the structure that fits.
US Medical Funding helps pharmacists and investors finance independent pharmacy acquisitions under a variety of structures. Learn more about our pharmacy acquisition financing.
